You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Original Contributions A 24-Week Open-Label Extension Study of Memantine in Moderate to Severe Alzheimer Disease
Barry Reisberg; Rachelle Doody; Albrecht Stöffler; Frederick Schmitt; Steven Ferris; Hans Jörg Möbius
Arch Neurol 2006; 63: 49-54.
[Abstract][Full text][PDF]
Clinical Trials Effects of Testosterone on Cognition and Mood in Male Patients With Mild Alzheimer Disease and Healthy Elderly Men
Po H. Lu; Donna A. Masterman; Ruth Mulnard; Carl Cotman; Bruce Miller; Kristine Yaffe; Erin Reback; Verna Porter; Ronald Swerdloff; Jeffrey L. Cummings
Arch Neurol 63.2.nct50002.
[Abstract][Full text][]
Clinical Trials Response to Interferon Beta-1a Treatment in African American Multiple Sclerosis Patients
Bruce A. C. Cree; Ahmad Al-Sabbagh; Randy Bennett; Douglas Goodin
Arch Neurol 2005; 62: 1681-1683.
[Abstract][Full text][PDF]
Original Contributions Treatment of Myasthenia Gravis Exacerbation With Intravenous Immunoglobulin: A Randomized Double-blind Clinical Trial
Philippe Gajdos; Christine Tranchant; Bernard Clair; Francis Bolgert; Bruno Eymard; Tanya Stojkovic; Shahram Attarian; Sylvie Chevret; Myasthenia Gravis Clinical Study Group
Arch Neurol 2005; 62: 1689-1693.
[Abstract][Full text][PDF]
Editorials Double-Blind, Placebo-Controlled Trials for Surgical Interventions in Parkinson Disease
Original Contributions Science and Ethics of Sham Surgery: A Survey of Parkinson Disease Clinical Researchers
Scott Y. H. Kim; Samuel Frank; Robert Holloway; Carol Zimmerman; Renee Wilson; Karl Kieburtz
Arch Neurol 2005; 62: 1357-1360.
[Abstract][Full text][PDF]
Correspondence Reexamination of the TEMPO Study—Reply
Andrew Siderowf; Shirley Eberly; David Oakes; Ira Shoulson; for the Parkinson Study Group TEMPO Steering Committee
Arch Neurol 2005; 62: 1321-a.
[Extract][Full text][PDF]
Clinical Trials Metabolic Patterns Associated With the Clinical Response to Galantamine Therapy: A Fludeoxyglucose F 18 Positron Emission Tomographic Study
Michael S. Mega; Ivo D. Dinov; Verna Porter; George Chow; Erin Reback; Paras Davoodi; Susan M. O’Connor; Michele F. Carter; Herminia Amezcua; Jeffrey L. Cummings
Arch Neurol 2005; 62: 721-728.
[Abstract][Full text][PDF]
